May 27, 2020
Aerpio Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative Announce the Selection of Razuprotafib for Evaluation in the I-SPY COVID Trial for the Treatment of Acute Respiratory Distress Syndrome in COVID-19 Patients
May 18, 2020
Wize Pharma's Strategic Transaction Partner Bonus BioGroup Reports Successful Treatment of Acute Pneumonia in Preclinical COVID-19 Model
May 12, 2020
Citius Pharmaceuticals Issues May 2020 Shareholder Letter
May 07, 2020
Vivace's AI solution offers effective early warning system for COVID-19 patients; hospitals offered free trial amid outbreak
Apr 28, 2020
Quantum Leap Healthcare's I-SPY 2 Investigators, ARDS Experts and COVID R&D Consortium Unite to Bring Success from the I-SPY Adaptive Platform Clinical Trial to COVID-19 ARDS ICU Patients
Apr 15, 2020
Roivant Doses First Patient in Pivotal BREATHE Clinical Trial Evaluating Gimsilumab in COVID-19 Patients for the Prevention and Treatment of Acute Respiratory Distress Syndrome
Apr 14, 2020
COVID-19 ARDS Patients Added to Healios ONE-BRIDGE Study
Apr 10, 2020
Enzychem Lifesciences Announces Filing of U.S. Provisional Patent for EC-18 for the Treatment of COVID-19
Apr 09, 2020
Celularity Expands Strategic Collaboration with United Therapeutics Corporation to COVID-19 Infection and Acute Respiratory Distress Syndrome
Apr 02, 2020
Ampio Pharmaceutical's Application to the FDA for a Clinical Study of Ampion(TM) to Treat COVID-19 Induced Acute Respiratory Distress Syndrome (ARDS) featured in FOX News (VIDEO)
Apr 01, 2020
FibroGenesis Files Expanded Patent Coverage for its Fibroblast Cell Therapy to treat Coronavirus (COVID-19) ARDS
Apr 01, 2020
Citius Signs Exclusive Option with Novellus to License Novel Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19
Mar 26, 2020
RELIEF THERAPEUTICS and NeuroRx, Inc. File FDA IND for Aviptadil to Treat COVID-19-induced Respiratory Distress
Mar 26, 2020
Regarding HLCM051 for Acute Respiratory Distress Syndrome (ARDS) Caused by COVID -19
Mar 24, 2020
Windtree to Pursue Clinical Study of Lung Injury Treatment in COVID-19 Patients with its KL4 Surfactant Therapy
Mar 18, 2020
Roivant Announces Development of Anti-GM-CSF Monoclonal Antibody to Prevent and Treat Acute Respiratory Distress Syndrome (ARDS) in Patients with COVID-19
Mar 10, 2020
FibroGenesis Files Patent Using its Fibroblast Cell Therapy for Coronavirus (COVID-19) ARDS
Jan 10, 2020
VERO Biotech, Leaders in the Development of Innovative Technologies for Inhaled Nitric Oxide Delivery, to Present at Biotech Showcase 2020
Jan 10, 2020
Biomarck Pharmaceuticals to Participate in 38th Annual J.P. Morgan Healthcare Conference on Thursday, January 16th, 2020
Nov 17, 2019
Mezzion Pharma announces the presentation of the FUEL Trial data at the American Heart Association Meeting in Philadelphia